ELV

Elevance Health, Inc.

HealthcareHealthcare PlansNASDAQ

$393.19

+$3.40 (0.86%)today

Conviction

0/ 10

Fair Value$380.95

Upside-3.11%

Signal0

Market Cap$69.1B

52W Range$273.71–$458.75

Next EarningsApr 22

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$3900.83

Current Price$286.39

Upside / Down+1262.1%

P(Undervalued)100.0%

P(20%+ Up)100.0%

P(15%+ Down)0.0%

Fair Value Distribution — percentile bands

100.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

-2.1%/yr

±10.6% · revenue growth to justify current price

FCF-Based Reverse DCF

-4.5%/yr

±3.0% · FCF growth to justify current price

THE GAP

Market pricing margin expansion or capex normalization

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.

Trailing P/E12.4x

Forward P/E10.6x

P/S0.3x

EPS (TTM)$25.20

Analyst Target$380.95

Analyst Upside-3.1%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 2

Conviction: unchanged

ELV 2025 10-K: Integration Play with Medicaid/Individual Headwinds

ELV 10-K shows integrated health platform with defensive government revenue (32%) but facing 2026 headwinds: Medicaid redeterminations complete, enhanced PTCs expired 12/31/25. Star Ratings improvemen...